TY - JOUR
T1 - Legionnairesș disease in human immunodeficiency virus-infected patients
T2 - eight cases and review
AU - Blatt, Stephen P.
AU - Dolan, Matthew J.
AU - Hendrix, Craig W.
AU - Melcher, Gregory P.
N1 - Funding Information:
Received 4 February 1993; revised 15 July 1993. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or other Departments ofthe U.S. Government. Grant support: This work was supported by the United States Army Medical Research and Development Command (DAMD 17-88-2-8007). Reprints or correspondence: Major Stephen P. Blatt, Wilford Hall Medical Center/PSMI, Suite I, 2200 Bergquist Drive, Lack1and Air Force Base, Texas 78236-5300.
PY - 1994/2
Y1 - 1994/2
N2 - Despite being a well-known pathogen for immunocompromised patients, Legionella pneumophila has infrequently been described in persons with infection due to human immunodeficiency virus (HIV). Since 1986, we have identified eight cases of legionella pneumonia among seven HIV-infected persons enrolled in the HIV Natural History Study of the U.S. Air Force. The median CD4+ T cell count for these patients was 83/mm3; 50% of the cases occurred in persons for whom AIDS was previously diagnosed, and five of the cases were nosocomial. Six of the patients had coexistent pulmonary infections. None of the cases occurred among persons receiving prophylactic therapy with trimethoprim-sulfamethoxazole. Therapeutically, all patients appeared to respond well to standard antilegionella therapy or high doses of trimethoprim-sulfamethoxazole.Overall, these seven patients represent 1.7% of the patients with late-stage HIV infection (Walter Reed stage 5 or 6) in this cohort. L. pneumophila, although remaining anuncommon pathogen for HIV-infected patients, may produce serious disease in this population.HIV-infected persons should be considered at risk for legionnaires' disease, particularly in institutions where potable water supplies have become contaminated.
AB - Despite being a well-known pathogen for immunocompromised patients, Legionella pneumophila has infrequently been described in persons with infection due to human immunodeficiency virus (HIV). Since 1986, we have identified eight cases of legionella pneumonia among seven HIV-infected persons enrolled in the HIV Natural History Study of the U.S. Air Force. The median CD4+ T cell count for these patients was 83/mm3; 50% of the cases occurred in persons for whom AIDS was previously diagnosed, and five of the cases were nosocomial. Six of the patients had coexistent pulmonary infections. None of the cases occurred among persons receiving prophylactic therapy with trimethoprim-sulfamethoxazole. Therapeutically, all patients appeared to respond well to standard antilegionella therapy or high doses of trimethoprim-sulfamethoxazole.Overall, these seven patients represent 1.7% of the patients with late-stage HIV infection (Walter Reed stage 5 or 6) in this cohort. L. pneumophila, although remaining anuncommon pathogen for HIV-infected patients, may produce serious disease in this population.HIV-infected persons should be considered at risk for legionnaires' disease, particularly in institutions where potable water supplies have become contaminated.
UR - http://www.scopus.com/inward/record.url?scp=0028006488&partnerID=8YFLogxK
U2 - 10.1093/clinids/18.2.227
DO - 10.1093/clinids/18.2.227
M3 - Article
C2 - 8161631
AN - SCOPUS:0028006488
SN - 1058-4838
VL - 18
SP - 227
EP - 232
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -